Sumitomo Pharma has a performance score of 9 on a scale of 0 to 100. The entity has a beta of 0.15, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sumitomo Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sumitomo Pharma is expected to be smaller as well. Sumitomo Pharma right now has a risk of 0.51%. Please validate Sumitomo Pharma information ratio and day median price , to decide if Sumitomo Pharma will be following its existing price patterns.
Risk-Adjusted Performance
Fair
Weak
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sumitomo Pharma Co are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Sumitomo Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Begin Period Cash Flow
193.7 B
Total Cashflows From Investing Activities
-18.3 B
Sumitomo
Sumitomo Pharma Relative Risk vs. Return Landscape
If you would invest 1,100 in Sumitomo Pharma Co on September 28, 2025 and sell it today you would earn a total of 45.00 from holding Sumitomo Pharma Co or generate 4.09% return on investment over 90 days. Sumitomo Pharma Co is currently producing 0.0629% returns and takes up 0.5074% volatility of returns over 90 trading days. Put another way, 4% of traded pink sheets are less volatile than Sumitomo, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
Expected Return
Risk
Assuming the 90 days horizon Sumitomo Pharma is expected to generate 1.31 times less return on investment than the market. But when comparing it to its historical volatility, the company is 1.4 times less risky than the market. It trades about 0.12 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 of returns per unit of risk over similar time horizon.
Sumitomo Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sumitomo Pharma's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Sumitomo Pharma Co, and traders can use it to determine the average amount a Sumitomo Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.124
Best Portfolio
Best Equity
Good Returns
Average Returns
Small Returns
Cash
SMDPY
Average Risk
High Risk
Huge Risk
Negative Returns
Based on monthly moving average Sumitomo Pharma is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sumitomo Pharma by adding it to a well-diversified portfolio.
Sumitomo Pharma Fundamentals Growth
Sumitomo Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Sumitomo Pharma, and Sumitomo Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sumitomo Pink Sheet performance.
Evaluating Sumitomo Pharma's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Sumitomo Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sumitomo Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Sumitomo Pharma performance evaluation
Checking the ongoing alerts about Sumitomo Pharma for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Sumitomo Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Sumitomo Pharma has high likelihood to experience some financial distress in the next 2 years
Evaluating Sumitomo Pharma's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Sumitomo Pharma's pink sheet performance include:
Analyzing Sumitomo Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sumitomo Pharma's stock is overvalued or undervalued compared to its peers.
Examining Sumitomo Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Sumitomo Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sumitomo Pharma's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Sumitomo Pharma's pink sheet. These opinions can provide insight into Sumitomo Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Sumitomo Pharma's pink sheet performance is not an exact science, and many factors can impact Sumitomo Pharma's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for Sumitomo Pink Sheet Analysis
When running Sumitomo Pharma's price analysis, check to measure Sumitomo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sumitomo Pharma is operating at the current time. Most of Sumitomo Pharma's value examination focuses on studying past and present price action to predict the probability of Sumitomo Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sumitomo Pharma's price. Additionally, you may evaluate how the addition of Sumitomo Pharma to your portfolios can decrease your overall portfolio volatility.